Format

Send to

Choose Destination
Int Tinnitus J. 2002;8(1):50-3.

Clonazepam in the pharmacological treatment of vertigo and tinnitus.

Author information

1
Division of Neurootology, Department of Otorhinolaryngology and Communicative Disorders, Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo, Brazil. mauricio.gananca@globo.com

Abstract

We carried out a retrospective survey of 25 years of clinical experience with the use of clonazepam as a vestibular and tinnitus suppressant in the pharmacological treatment of vestibular or cochleovestibular disorders due to different causes. We reviewed the medical records of 3,357 outpatients treated with a 0.5 or 1.0-mg daily dosage of oral clonazepam during 60-180 days. Complete or substantial control of vertigo or nonvertiginous dizziness was achieved in 77.4% of the vertigo patients. Tinnitus was improved in 32.0% of the tinnitus patients. Light or mild drowsiness, depression, nightmares, or lowering of libido, reported by 16.9% of the patients as adverse side effects, tended to subside with continued therapy. We concluded that clonazepam is a very useful and safe drug for the symptomatic treatment of patients suffering from cochleovestibular disorders.

PMID:
14763236
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center